Endogenous androgen levels and well-being: Differences between premenopausal and postmenopausal women

Menopause

Volumn 13, Issue 1, 2006, Pages 65-71

  Bell, Robin J ^a,b   Donath, Susan ^a   Davison, Sonia L ^a   Davis, Susan R ^a  

^a MONASH UNIVERSITY   (Australia)

^b ALFRED HOSPITAL   (Australia)

Author keywords

Androgens; Dehydroepiandrosterone sulfate; Postmenopausal; Premenopausal; Well being

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; PRASTERONE; TESTOSTERONE; PRASTERONE SULFATE;

ADULT; AGE; AGED; ANDROGEN BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; DEMOGRAPHY; EXERCISE; FEMALE; HUMAN; LIFESTYLE; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; OBESITY; POSTMENOPAUSE; PREMENOPAUSE; QUESTIONNAIRE; RANDOMIZATION; SCORING SYSTEM; SMOKING; WELLBEING; ADOLESCENT; AFFECT; AGING; ANXIETY; BLOOD; DEPRESSION; ESTROGEN THERAPY; MARRIAGE; MIDDLE AGED; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; REGRESSION ANALYSIS;

ADOLESCENT; ADULT; AFFECT; AGED; AGING; ANDROGENS; ANDROSTENEDIONE; ANXIETY; DEHYDROEPIANDROSTERONE SULFATE; DEPRESSION; ESTROGEN REPLACEMENT THERAPY; EXERCISE; FEMALE; HUMANS; MARITAL STATUS; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; REGRESSION ANALYSIS; TESTOSTERONE;

EID: 33645979360     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.gme.0000191212.58856.96     Document Type: Article

References (26)

1. Shifren JL, Braunstein G, Simon J, et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000;343:682-688.
2. Goldstat R, Briganti E, Tran J, Wolfe R, Davis S. Transdermal testosterone improves mood, well being and sexual function in premenopausal women. Menopause 2003;10:390-398.
3. Arlt W, Callies F, Van Vlijmen JC, et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 1999;341:1013-1020.
4. Hunt P, Gurnell E, Huppert F. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. J Clin Endocrinol Metab 2000;85:4650-4656.
5. Dupuy H. The Psychological General Well-Being (PGWB) Index. In: W enger N, Mattson M, Furberg C, Elinson J, eds. Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. New York: Le Jacq Publishing, 1984:170-183.
6. Australian Bureau of Statistics. Census of Population and Housing - Socio-Economic Indexes for Areas, Australia. Canberra, Australia: Australian Bureau of Statistics, 2003.
7. Wan T, Livieratos B. Interpreting a general index of subjective well-being. Milbank Mem Fund 1978;56:531-556.
8. Goebelsmann U, Arce J, Thorneycroft L, Mishell D Jr. Serum testosterone concentrations in women throughout the menstrual cycle and following HCG administration. Am J Obstet Gynecol 1974;119:445-452.
9. Vermeulen A, Verdonck L, Kaufman M. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666-3672.
10. Sodergard R, Backstrom T, Shanhag V, Carstensen H. Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. J Steroid Biochem 1982;16:801-810.
11. Davison, SL, Bell R, Donath S, Montalto J, Davis SR. Androgen levels in adult females: changes with age, menopause and oophorectomy. J Clin Endocrinol Metab in press.
12. Australian Bureau of Statistics. SF-36 Population Norms 1995. Canberra, Australia. 1997, pp. 1-38.
13. McLennan W. Mental Health and Well-Being: Profile of Adults. Canberra, Australia: Australian Bureau of Statistics, 1997.
14. Brown W, Mishra G, Kenardy J, Dobson AA. Relationships between body mass index and well-being in young Australian women. Int J Obesity 2000;24:1360-1368.
15. Lee C, Russell A. Effects of physical activity on emotional well-being among older Australian women: cross-sectional and longitudinal analyses. J Psychosom Res 2003;54:156-160.
16. Dennerstein L, Lehert P, Guthrie JR. The effects of the menopausal transition and biopsychosocial factors on well-being. Arch Womens Ment Health 2002;5:15-22.
17. Mishra G, Ball K, Dobson A, Byles J, Warners Smith P. The measurement of socio-economic status: Investigation of gender-and age-specific indicators in Australia: National Health Survey 1995. Socl Indicators Res 2001;56:73-89.
18. Mishra G, Brown W, Dobson A. Physical and mental health: changes during menopause transition. Qual Life Res 2003;12:405-412.
19. Hays J, Okene J, Brunner R, Kotchen J, Manson JE, Patterson R. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 2003;348:1839-1854.
20. Zumoff B, Strain GW, Miller LK, Rosner W. Twenty-four hour mean plasma testosterone concentration declines with age in normal premenopausal women. J Clin Endocrinol Metab 1995;80:1429-1430.
21. Labrie F, Belanger A, Cusan L, Gomez J-L, Candas B. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metaboliltes during aging. J Clin Endocrinol Metab 1997;82:2396-2402.
22. Barnhart K, Freeman E, Grisso JA. The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life. J Clin Endocrinol Metab 1999;84:3896-3902.
23. Chen C, Weiss NS, Stanczyk FZ. Endogenous sex hormones and prostate cancer risk: a case-control study nested within the Carotene and Retinol Efficacy Trial. Cancer Epidemiol Biomarkers Prev 2003;12:1410-1416.
24. Lamar CA, Dorgan JF, Longcope C, Stanczyk FZ, Falk RT, Stephenson HE Jr. Serum sex hormones and breast cancer risk factors in postmenopausal women. Cancer Epidemiol. Biomarkers Prev 2003;12:380-383.
25. Haning JRV, Hackett R, Flood CA, Loughlin J, Zhao Q, Longcope C. Plasma dehydroepiandrosterone sulfate serves as a prehormone for 48% of follicular fluid testosterone during treatment with menotropins. J Clin Endocrinol Metab 1993;76:1301-1307.
26. Labrie F, Luu-The V, Labrie C, et al. Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. Endocr Rev 2003;24:152-182.